The failure of rotavirus (RV) vaccines in infants underscores a need for more effective vaccination strategies and an improved understanding of the development of mucosal immunity to human rotavirus (HRV) in infants. High levels of maternal antibodies to RV in the neonate's circulation and in breast milk may interfere with successful immunization against RV and hinder assessment of active immunity to RV in vaccine trials. Thus, to facilitate RV vaccine development we will investigate the development of mucosal immunity to RV in neonates and delineate the effect of maternal antibodies on immunity to RV. Because of the difficulty in analyzing mucosal immune responses in infants, we will rely on the use of gnotobiotic (Gn) pigs for our studies. The neonatal Gn pig is an ideal animal because it is highly susceptible to HRV infection and disease, it resembles humans in gastrointestinal physiology and it is born without maternal antibodies. We will investigate the development of systemic and local (intestinal) antibody and cellular immune responses to oral inoculation with virulent HRV (mimic natural exposure) and live attenuated HRV (mimic oral vaccines) and parenterally administered HRV recombinant proteins (mimic subunit vaccines) in three experimental groups of Gn pigs: pigs devoid of maternal RV antibodies (immunologically virgin); pigs with circulating maternal RV antibodies (represent formula-fed infants); and pigs with maternal circulating and milk RV antibodies (represent breast- fed infants). Finally selected immunoenhancers (mucosal adjuvants, cytokines) will be evaluated for their ability to enhance the development of active immunity to HRV and to counter suppressive effects of maternal antibodies on active immune responses to HRV. Antibody responses to HRV and RV proteins (VP4 and VP7) in the experimental Gn pigs will be detected and quantitated by neutralization, isotype and epitope-blocking ELISA and ELISPOT assays. Cellular immune responses will be assessed by lymphoproliferation assays and cytokine profiles. Cytokines will be examined by ELISPOT, RT-PCR and northern blot with an emphasis on delineating Th1- and Th2-like cells. To interpret the results of lymphoproliferation and cytokine analysis, we will phenotype lymphoid cells from the intestine using monoclonal antibodies and flow cytometry. Our data should elucidate the components and tissue sites of the immune system affected by maternal RV antibodies and identify future targets for immunoenhancement of the neonatal immune response to oral vaccines.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI037111-03
Application #
2073727
Study Section
Special Emphasis Panel (SRC (84))
Project Start
1994-09-30
Project End
1999-08-31
Budget Start
1996-09-01
Budget End
1999-08-31
Support Year
3
Fiscal Year
1996
Total Cost
Indirect Cost
Name
Ohio State University
Department
Zoology
Type
Schools of Earth Sciences/Natur
DUNS #
098987217
City
Columbus
State
OH
Country
United States
Zip Code
43210
Nguyen, Trang V; Yuan, Lijuan; Azevedo, Marli S P et al. (2007) Transfer of maternal cytokines to suckling piglets: in vivo and in vitro models with implications for immunomodulation of neonatal immunity. Vet Immunol Immunopathol 117:236-48
Nguyen, Trang V; Yuan, Lijuan; P Azevedo, Marli S et al. (2006) Low titer maternal antibodies can both enhance and suppress B cell responses to a combined live attenuated human rotavirus and VLP-ISCOM vaccine. Vaccine 24:2302-16
Nguyen, Trang V; Yuan, Lijuan; Azevedo, Marli S P et al. (2006) High titers of circulating maternal antibodies suppress effector and memory B-cell responses induced by an attenuated rotavirus priming and rotavirus-like particle-immunostimulating complex boosting vaccine regimen. Clin Vaccine Immunol 13:475-85
Azevedo, M S; Yuan, L; Jeong, K-I et al. (2005) Viremia and nasal and rectal shedding of rotavirus in gnotobiotic pigs inoculated with Wa human rotavirus. J Virol 79:5428-36
Azevedo, Marli S P; Yuan, Lijuan; Iosef, Cristiana et al. (2004) Magnitude of serum and intestinal antibody responses induced by sequential replicating and nonreplicating rotavirus vaccines in gnotobiotic pigs and correlation with protection. Clin Diagn Lab Immunol 11:12-20
Gonzalez, A M; Nguyen, T V; Azevedo, M S P et al. (2004) Antibody responses to human rotavirus (HRV) in gnotobiotic pigs following a new prime/boost vaccine strategy using oral attenuated HRV priming and intranasal VP2/6 rotavirus-like particle (VLP) boosting with ISCOM. Clin Exp Immunol 135:361-72
Nguyen, T V; Iosef, C; Jeong, K et al. (2003) Protection and antibody responses to oral priming by attenuated human rotavirus followed by oral boosting with 2/6-rotavirus-like particles with immunostimulating complexes in gnotobiotic pigs. Vaccine 21:4059-70
Kim, Yunjeong; Chang, Kyeong Ok; Kim, Won Yong et al. (2002) Production of hybrid double- or triple-layered virus-like particles of group A and C rotaviruses using a baculovirus expression system. Virology 302:1-8
Iosef, Cristiana; Chang, Kyeong-Ok; Azevedo, Marli S P et al. (2002) Systemic and intestinal antibody responses to NSP4 enterotoxin of Wa human rotavirus in a gnotobiotic pig model of human rotavirus disease. J Med Virol 68:119-28
Iosef, Cristiana; Van Nguyen, Trang; Jeong, Kwang il et al. (2002) Systemic and intestinal antibody secreting cell responses and protection in gnotobiotic pigs immunized orally with attenuated Wa human rotavirus and Wa 2/6-rotavirus-like-particles associated with immunostimulating complexes. Vaccine 20:1741-53

Showing the most recent 10 out of 24 publications